102 related articles for article (PubMed ID: 20826570)
41. Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria.
Howie AJ; Kizaki T; Beaman M; Morland CM; Birtwistle RJ; Adu D; Michael J; Williams AJ; Walls J; Matsuyama M
J Pathol; 1989 Feb; 157(2):141-51. PubMed ID: 2921674
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effect of sulphated hyaluronic acid, a potential selectin-blocking agent, on experimental progressive mesangial proliferative glomerulonephritis.
Matsuda M; Shikata K; Shimizu F; Suzuki Y; Miyasaka M; Kawachi H; Kawashima H; Wada J; Sugimoto H; Shikata Y; Ogawa D; Tojo SJ; Akima K; Makino H
J Pathol; 2002 Nov; 198(3):407-14. PubMed ID: 12375274
[TBL] [Abstract][Full Text] [Related]
43. Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritis.
Sakai N; Iseki K; Suzuki S; Mori T; Hagino S; Zhang Y; Yokoya S; Kawasaki Y; Suzuki J; Isome M; Wada I; Homma Y; Suzuki H
Pathol Int; 2005 Jan; 55(1):19-26. PubMed ID: 15660699
[TBL] [Abstract][Full Text] [Related]
44. Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis.
Goto S; Yamamoto T; Feng L; Yaoita E; Hirose S; Fujinaka H; Kawasaki K; Hattori R; Yui Y; Wilson CB
Am J Pathol; 1995 Oct; 147(4):1133-41. PubMed ID: 7573358
[TBL] [Abstract][Full Text] [Related]
45. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates prolonged mesangial lesions in experimental progressive glomerulonephritis.
Wan Y; Sun W; Zhang H; Yan Q; Chen P; Dou C; Yang H; Ge M
Nephron Exp Nephrol; 2010; 114(1):e7-e14. PubMed ID: 19816047
[TBL] [Abstract][Full Text] [Related]
46. Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis.
Kasuga H; Ito Y; Sakamoto S; Kawachi H; Shimizu F; Yuzawa Y; Matsuo S
Kidney Int; 2001 Nov; 60(5):1745-55. PubMed ID: 11703592
[TBL] [Abstract][Full Text] [Related]
47. Contrasting dose-effects of multi-glycoside of Tripterygium wilfordii HOOK. f. on glomerular inflammation and hepatic damage in two types of anti-Thy1.1 glomerulonephritis.
Wan YG; Zhao Q; Sun W; Zhang HL; Li M; Wei QX; Wu W; Yue LJ; Wang Q
J Pharmacol Sci; 2012; 118(4):433-46. PubMed ID: 22447300
[TBL] [Abstract][Full Text] [Related]
48. Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis.
Rampino T; Soccio G; Gregorini M; Guidetti C; Marasà M; Maggio M; Panichi V; Migliori M; Libetta C; Dal Canton A
J Am Soc Nephrol; 2007 May; 18(5):1486-96. PubMed ID: 17409315
[TBL] [Abstract][Full Text] [Related]
49. Intrauterine growth retardation aggravates the course of acute mesangioproliferative glomerulonephritis in the rat.
Plank C; Ostreicher I; Hartner A; Marek I; Struwe FG; Amann K; Hilgers KF; Rascher W; Dötsch J
Kidney Int; 2006 Dec; 70(11):1974-82. PubMed ID: 17051140
[TBL] [Abstract][Full Text] [Related]
50. Glomerular capillary regeneration and endothelial cell apoptosis in both reversible and progressive models of glomerulonephritis.
Shimizu A; Kitamura H; Masuda Y; Ishizaki M; Sugisaki Y; Yamanaka N
Contrib Nephrol; 1996; 118():29-40. PubMed ID: 8744037
[TBL] [Abstract][Full Text] [Related]
51. Ion-Channel modulator TH1177 reduces glomerular injury and serum creatinine in chronic mesangial proliferative disease in rats.
Cove-Smith A; Sharpe CC; Shattock MJ; Hendry BM
BMC Nephrol; 2020 May; 21(1):187. PubMed ID: 32429914
[TBL] [Abstract][Full Text] [Related]
52. Intussusceptive capillary growth is required for glomerular repair in rat Thy-1.1 nephritis.
Notoya M; Shinosaki T; Kobayashi T; Sakai T; Kurihara H
Kidney Int; 2003 Apr; 63(4):1365-73. PubMed ID: 12631352
[TBL] [Abstract][Full Text] [Related]
53. Crescent-forming mechanism in an irreversible Thy-1 model in rats.
Oyanagi A; Orikasa M; Kawachi H; Ito Y; Koike H; Gejo F; Shimizu F
Nephron; 2001 Dec; 89(4):439-47. PubMed ID: 11721163
[TBL] [Abstract][Full Text] [Related]
54. Agmatine inhibits cell proliferation and improves renal function in anti-thy-1 glomerulonephritis.
Ishizuka S; Cunard R; Poucell-Hatton S; Wead L; Lortie M; Thomson SC; Gabbai FB; Satriano J; Blantz RC
J Am Soc Nephrol; 2000 Dec; 11(12):2256-2264. PubMed ID: 11095648
[TBL] [Abstract][Full Text] [Related]
55. Oxidant stress in hyperlipidemia-induced renal damage.
Scheuer H; Gwinner W; Hohbach J; Gröne EF; Brandes RP; Malle E; Olbricht CJ; Walli AK; Gröne HJ
Am J Physiol Renal Physiol; 2000 Jan; 278(1):F63-74. PubMed ID: 10644656
[TBL] [Abstract][Full Text] [Related]
56. Darbepoetin α ameliorates neuronal damage in a rat model of acute ethanol intoxication.
Seymen P; Aytac E; Esen F; Tel C; Demir F; Genc H; Uzun H; Oz B; Altug T; Seymen HO
Int J Neurosci; 2013 Feb; 123(2):99-103. PubMed ID: 23057801
[TBL] [Abstract][Full Text] [Related]
57. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.
Migliori M; Giovannini L; Panichi V; Filippi C; Taccola D; Origlia N; Mannari C; Camussi G
Int J Immunopathol Pharmacol; 2005; 18(4):779-90. PubMed ID: 16388728
[TBL] [Abstract][Full Text] [Related]
58. Effects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy.
Hussein AM; Eldosoky M; Handhle A; Elserougy H; Sarhan M; Sobh MA; Hussiny ME; El Nashar EM
Int Urol Nephrol; 2016 Feb; 48(2):287-97. PubMed ID: 26660954
[TBL] [Abstract][Full Text] [Related]
59. Interferon-beta reduces proteinuria in experimental glomerulonephritis.
Satchell SC; Buchatska O; Khan SB; Bhangal G; Tasman CH; Saleem MA; Baker DP; Lobb RR; Smith J; Cook HT; Mathieson PW; Pusey CD
J Am Soc Nephrol; 2007 Nov; 18(11):2875-84. PubMed ID: 17942968
[TBL] [Abstract][Full Text] [Related]
60. Proliferative glomerulonephritis in rats: evidence that mononuclear phagocytes infiltrating the glomeruli stimulate the proliferation of endothelial and mesangial cells.
Dubois CH; Foidart JB; Hautier MB; Dechenne CA; Lemaire MJ; Mahieu PR
Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):91-104. PubMed ID: 6785101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
